Astera Labs, Inc. (ALAB) experienced a significant price decline, plummeting 5.17% during intraday trading on Tuesday.

The sharp drop followed a rating downgrade by Northland Capital, which cut its recommendation on the stock to Market Perform from Outperform. This analyst action, reported in research roundups and specific alerts, is a primary catalyst for the negative price movement.

Recent analysis had also highlighted concerns that the stock's valuation may have become stretched following a period of strong performance and positive coverage, adding to the selling pressure during the session.